Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma

---

Copy For Citation

Kahramanoglu I., DEMİRKIRAN F., TURAN H., BEŞE T. T., Cebi S., İLVAN Ş., ...More

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, vol.43, no.1, pp.34-42, 2021 (ESCI)

• Publication Type: Article / Article
• Volume: 43 Issue: 1
• Publication Date: 2021
• Doi Number: 10.1016/j.jogc.2020.06.021
• Journal Name: JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, CINAHL, EMBASE, MEDLINE
• Page Numbers: pp.34-42
• Keywords: carcinosarcoma, mixed tumor, mullerian, uterine neoplasms, radiotherapy, STAGE-I, RADIATION-THERAPY, SURVIVAL, PATTERNS, LYMPHADENECTOMY, GUIDELINES, SARCOMA, UTERUS, IMPACT
• Istanbul University Affiliated: Yes

Abstract

Objective: To determine the impact of adjuvant therapy and other factors associated with the recurrence and survival of patients with uterine carcinosarcoma (UCS).